Dutch Cancer Foundation (KWF) grant for Dömling
Prof. Alex Dömling, Drug Design group of GRIP, together with co-workers of the UMCG (Profs. H. Nijmans and P. Elsinga) recently was awarded a grant of approx. €840.000 by the Dutch Cancer Foundation (KWF) research and implementation programme. The project is titled: Non-invasive whole-body imaging of immune checkpoints using radiolabeled small molecules as predictive biomarker for response to therapy.
In the project, small molecules will be developed for use as PET tracers and provide proof-of-concept for their use as a predictive biomarker. The multidisciplinary team of clinicians, chemists, nuclear medicine specialists and preclinical research staff involved in this project makes us uniquely suited to develop an imaging product with near-future clinical applications.
| Last modified: | 08 June 2017 11.25 a.m. |
More news
-
15 April 2024
Single-molecule engineering niche in Gravitation research
With her expertise in single-molecule techniques, Dr. Kasia Tych (GBB) will contribute to a big Grvitation-research programme
-
15 April 2024
Night vision with artificial atoms
Every two weeks, UG Makers puts the spotlight on a researcher who has created something tangible, ranging from homemade measuring equipment for academic research to small or larger products that can change our daily lives. That is how UG...
-
09 April 2024
University of Groningen to become member of the 4TU Stan Ackermans Institute
Through this membership, the two EngD programmes in Autonomous Systems and in Sustainable Process Design at the Faculty of Science and Engineering will be added to this partnership with the 4TU from September 2024